Shunsuke Katsuki
Overview
Explore the profile of Shunsuke Katsuki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noda E, Matsushima S, Hashimoto T, Tsutsui Y, Misumi K, Enzan N, et al.
Sci Rep
. 2025 Jan;
15(1):3918.
PMID: 39890823
Moderate/severe anemia [hemoglobin (Hb) < 10 g/dL] is recommended to be treated in patients with renal anemia. However, the optimal therapeutic target for Hb levels in patients with heart failure...
2.
Yoshida S, Hayashi H, Kawahara T, Katsuki S, Kimura M, Hino R, et al.
Circ Res
. 2024 Dec;
136(1):26-40.
PMID: 39629565
Background: Myofibroblasts are primary cells involved in chronic response-induced cardiac fibrosis. Fibroblast activation protein (FAP) is a relatively specific marker of activated myofibroblasts and a potential target molecule. This study...
3.
Nakashima H, Shinohara K, Matsumoto S, Nakashima R, Yoshida D, Ono Y, et al.
Hypertens Res
. 2024 Nov;
48(2):672-680.
PMID: 39609645
The pathogenesis of heart failure with preserved ejection fraction (HFpEF) remains unclear, and effective treatments are limited. HFpEF is more prevalent in females, indicating potential gender differences in its pathogenesis....
4.
Izumi R, Hashimoto T, Kisanuki H, Ikuta K, Otsuru W, Asakawa S, et al.
Cardiooncology
. 2024 Nov;
10(1):82.
PMID: 39574216
The advent of immune checkpoint inhibitors (ICIs) has significantly improved cancer treatment. With the increasing use of ICIs, ICI-related myocarditis has been recognized. However, an evidence-based therapeutic strategy has not...
5.
Baba I, Matoba T, Katsuki S, Koga J, Kawahara T, Kimura M, et al.
Sci Rep
. 2024 Aug;
14(1):19601.
PMID: 39179643
No abstract available.
6.
Katsuki S, Kumar Jha P, Aikawa E, Aikawa M
Front Cardiovasc Med
. 2024 Aug;
11:1431398.
PMID: 39149582
Recent clinical trials demonstrated that proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors reduce cardiovascular events without affecting systemic inflammation in the patients with coronary artery disease, as determined by high sensitivity...
7.
Baba I, Matoba T, Katsuki S, Koga J, Kawahara T, Kimura M, et al.
Sci Rep
. 2024 Jul;
14(1):16323.
PMID: 39009669
Vascular calcification, which is a major complication of diabetes mellitus, is an independent risk factor for cardiovascular disease. Osteogenic differentiation of vascular smooth muscle cells (VSMCs) is one of the...
8.
Koga J, Umezu R, Kondo Y, Shirouzu T, Orkhonselenge N, Ueno H, et al.
Atherosclerosis
. 2024 Jul;
396:118524.
PMID: 38972156
Background And Aims: In advanced atherosclerotic lesions, macrophage deaths result in necrotic core formation and plaque vulnerability. Cyclophilin D (CypD) is a mitochondria-specific cyclophilin involved in the process of cell...
9.
Kimura M, Matoba T, Nakano Y, Katsuki S, Sakamoto K, Nishihara M, et al.
Circ Rep
. 2024 Jun;
6(6):191-200.
PMID: 38860181
Coronavirus disease 2019 (COVID-19) has impacted on cardiovascular disease. However, it remains unclear whether the COVID-19 pandemic has impacted on disease severity and patients' prognosis of acute myocardial infarction (AMI)...
10.
Matoba T, Nakano Y, Katsuki S, Ide T, Matsushima S, Fujino T, et al.
Circ J
. 2024 Mar;
88(4):615-619.
PMID: 38448007
The 87Annual Meeting of the Japanese Circulation Society (JCS2023) was held in March 2023 in Fukuoka, Japan, marking the first in-person gathering after the COVID-19 pandemic. With the theme of...